EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Statistics

Total Valuation

TPEX:4183 has a market cap or net worth of TWD 333.20 million. The enterprise value is 374.51 million.

Market Cap	333.20M
Enterprise Value	374.51M

Important Dates

The last earnings date was Thursday, May 7, 2026.

Earnings Date	May 7, 2026
Ex-Dividend Date	Aug 28, 2025

Share Statistics

TPEX:4183 has 23.80 million shares outstanding.

Current Share Class	23.80M
Shares Outstanding	23.80M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	57.04%
Owned by Institutions (%)	n/a
Float	7.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.75
PB Ratio	1.24
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.55
EV / Sales	0.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.23

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.51.

Current Ratio	2.43
Quick Ratio	1.69
Debt / Equity	0.51
Debt / EBITDA	n/a
Debt / FCF	-3.00
Interest Coverage	-9.59

Financial Efficiency

Return on equity (ROE) is -7.44% and return on invested capital (ROIC) is -6.48%.

Return on Equity (ROE)	-7.44%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-6.48%
Return on Capital Employed (ROCE)	-5.41%
Weighted Average Cost of Capital (WACC)	3.67%
Revenue Per Employee	4.07M
Profits Per Employee	-195,743
Employee Count	109
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.08% in the last 52 weeks. The beta is 0.08, so TPEX:4183's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-27.08%
50-Day Moving Average	15.54
200-Day Moving Average	17.83
Relative Strength Index (RSI)	35.14
Average Volume (20 Days)	11,369

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4183 had revenue of TWD 443.44 million and -21.34 million in losses. Loss per share was -0.90.

Revenue	443.44M
Gross Profit	76.35M
Operating Income	-19.72M
Pretax Income	-22.44M
Net Income	-21.34M
EBITDA	-7.66M
EBIT	-19.72M
Loss Per Share	-0.90

Balance Sheet

The company has 95.36 million in cash and 136.68 million in debt, with a net cash position of -41.31 million or -1.74 per share.

Cash & Cash Equivalents	95.36M
Total Debt	136.68M
Net Cash	-41.31M
Net Cash Per Share	-1.74
Equity (Book Value)	268.82M
Book Value Per Share	11.29
Working Capital	187.46M

Cash Flow

In the last 12 months, operating cash flow was -28.12 million and capital expenditures -17.38 million, giving a free cash flow of -45.50 million.

Operating Cash Flow	-28.12M
Capital Expenditures	-17.38M
Depreciation & Amortization	12.06M
Net Borrowing	33.92M
Free Cash Flow	-45.50M
FCF Per Share	-1.91

Margins

Gross margin is 17.22%, with operating and profit margins of -4.45% and -4.81%.

Gross Margin	17.22%
Operating Margin	-4.45%
Pretax Margin	-5.06%
Profit Margin	-4.81%
EBITDA Margin	-1.73%
EBIT Margin	-4.45%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.67, which amounts to a dividend yield of 4.84%.

Dividend Per Share	0.67
Dividend Yield	4.84%
Dividend Growth (YoY)	-16.25%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	4.84%
Earnings Yield	-6.40%
FCF Yield	-13.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 8, 2014. It was a forward split with a ratio of 1.04.

Last Split Date	Oct 8, 2014
Split Type	Forward
Split Ratio	1.04

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a